These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 36803541)

  • 1. Assessment of artemisinin tolerance in Plasmodium falciparum clinical isolates in children with uncomplicated malaria in Ghana.
    Ahorhorlu SY; Quashie NB; Jensen RW; Kudzi W; Nartey ET; Duah-Quashie NO; Zoiku F; Dzudzor B; Wang CW; Hansson H; Alifrangis M; Adjei GO
    Malar J; 2023 Feb; 22(1):58. PubMed ID: 36803541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo/ex vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso.
    Lingani M; Bonkian LN; Yerbanga I; Kazienga A; Valéa I; Sorgho H; Ouédraogo JB; Mens PF; Schallig HDFH; Ravinetto R; d'Alessandro U; Tinto H
    Malar J; 2020 Jan; 19(1):8. PubMed ID: 31906948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017.
    Davlantes E; Dimbu PR; Ferreira CM; Florinda Joao M; Pode D; Félix J; Sanhangala E; Andrade BN; Dos Santos Souza S; Talundzic E; Udhayakumar V; Owens C; Mbounga E; Wiesner L; Halsey ES; Martins JF; Fortes F; Plucinski MM
    Malar J; 2018 Apr; 17(1):144. PubMed ID: 29615039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerance of Gambian Plasmodium falciparum to Dihydroartemisinin and Lumefantrine Detected by
    Mbye H; Bojang F; Jawara AS; Njie B; Mohammed NI; Okebe J; D'Alessandro U; Amambua-Ngwa A
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33020162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment Failure in a UK Malaria Patient Harboring Genetically Variant Plasmodium falciparum From Uganda With Reduced In Vitro Susceptibility to Artemisinin and Lumefantrine.
    van Schalkwyk DA; Pratt S; Nolder D; Stewart LB; Liddy H; Muwanguzi-Karugaba J; Beshir KB; Britten D; Victory E; Rogers C; Millard J; Brown M; Nabarro LE; Taylor A; Young BC; Chiodini PL; Sutherland CJ
    Clin Infect Dis; 2024 Feb; 78(2):445-452. PubMed ID: 38019958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of artemether-lumefantrine for treating uncomplicated malaria in low- and high-transmission areas of Ghana.
    Mawuli MA; Amoah LE; Cui L; Quashie NB; Afrane YA
    Malar J; 2024 Feb; 23(1):40. PubMed ID: 38317164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring of efficacy, tolerability and safety of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Lambaréné, Gabon: an open-label clinical trial.
    Adegbite BR; Edoa JR; Honkpehedji YJ; Zinsou FJ; Dejon-Agobe JC; Mbong-Ngwese M; Lotola-Mougueni F; Koehne E; Lalremruata A; Kreidenweiss A; Nguyen TT; Kun J; Agnandji ST; Lell B; Safiou AR; Obone Atome FA; Mombo-Ngoma G; Ramharter M; Velavan TP; Mordmüller B; Kremsner PG; Adegnika AA
    Malar J; 2019 Dec; 18(1):424. PubMed ID: 31842893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of artesunate-amodiaquine and artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria in Madagascar, 2018.
    Dentinger CM; Rakotomanga TA; Rakotondrandriana A; Rakotoarisoa A; Rason MA; Moriarty LF; Steinhardt LC; Kapesa L; Razafindrakoto J; Svigel SS; Lucchi NW; Udhayakumar V; Halsey ES; Ratsimbasoa CA
    Malar J; 2021 Nov; 20(1):432. PubMed ID: 34732201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic efficacy of artesunate-amodiaquine and artemether-lumefantrine combinations for uncomplicated malaria in 10 sentinel sites across Ghana: 2015-2017.
    Abuaku B; Duah-Quashie NO; Quaye L; Matrevi SA; Quashie N; Gyasi A; Owusu-Antwi F; Malm K; Koram K
    Malar J; 2019 Jun; 18(1):206. PubMed ID: 31234874
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Zhao W; Li X; Yang Q; Zhou L; Duan M; Pan M; Qin Y; Li X; Wang X; Zeng W; Zhao H; Sun K; Zhu W; Afrane Y; Amoah LE; Abuaku B; Duah-Quashie NO; Huang Y; Cui L; Yang Z
    Front Cell Infect Microbiol; 2022; 12():1015957. PubMed ID: 36310880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of artesunate-amodiaquine, dihydroartemisinin-piperaquine and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Maradi, Niger.
    Grandesso F; Guindo O; Woi Messe L; Makarimi R; Traore A; Dama S; Laminou IM; Rigal J; de Smet M; Ouwe Missi Oukem-Boyer O; Doumbo OK; Djimdé A; Etard JF
    Malar J; 2018 Jan; 17(1):52. PubMed ID: 29370844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic efficacy of artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Chad: clinical and genetic surveillance.
    Issa MS; Warsame M; Mahamat MHT; Saleh IDM; Boulotigam K; Djimrassengar H; Issa AH; Abdelkader O; Hassoumi M; Djimadoum M; Doderer-Lang C; Ndihiokubwayo JB; Rasmussen C; Menard D
    Malar J; 2023 Aug; 22(1):240. PubMed ID: 37612601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased susceptibility of Plasmodium falciparum to both dihydroartemisinin and lumefantrine in northern Uganda.
    Tumwebaze PK; Conrad MD; Okitwi M; Orena S; Byaruhanga O; Katairo T; Legac J; Garg S; Giesbrecht D; Smith SR; Ceja FG; Nsobya SL; Bailey JA; Cooper RA; Rosenthal PJ
    Nat Commun; 2022 Oct; 13(1):6353. PubMed ID: 36289202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
    West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
    Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine and prevalence of molecular markers of anti-malarial drug resistance in children in Togo in 2021.
    Dorkenoo AM; Warsame M; Ataba E; Hemou M; Yakpa K; Sossou E; Mitigmsagou M; Teou CD; Caspar E; Ma L; Djadou KE; Atcha-Oubou T; Rasmussen C; Menard D
    Malar J; 2024 Apr; 23(1):92. PubMed ID: 38570791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimalarial drug efficacy and resistance in malaria-endemic countries in HANMAT-PIAM_net countries of the Eastern Mediterranean Region 2016-2020: Clinical and genetic studies.
    Adam M; Nahzat S; Kakar Q; Assada M; Witkowski B; Tag Eldin Elshafie A; Abuobaida D; Safi N; Khan MA; Nagi M; Mustafa SA; Kohestani K; Muhammad J; Khim N; Al-Hadi M; Elfaki TM; Habib MN; Khairy AKA; Hamid H; Uddin Z; Amer Y; Hassan AH; Elhag MS; Sediqi AW; Kakar I; Abdul-Ghani R; Amran JGH; Abdallrahim TA; Tamim MS; Aljasari A; Rasmussen C; Azkoul L; Warsame M
    Trop Med Int Health; 2023 Oct; 28(10):817-829. PubMed ID: 37705047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of artemisinin-based combination treatment failure in patients returning from sub-Saharan Africa with P. falciparum malaria.
    Grossman T; Vainer J; Paran Y; Studentsky L; Manor U; Dzikowski R; Schwartz E
    J Travel Med; 2023 Dec; 30(8):. PubMed ID: 37606241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Papua New Guinea.
    Tavul L; Hetzel MW; Teliki A; Walsh D; Kiniboro B; Rare L; Pulford J; Siba PM; Karl S; Makita L; Robinson L; Kattenberg JH; Laman M; Oswyn G; Mueller I
    Malar J; 2018 Oct; 17(1):350. PubMed ID: 30290825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of parasite genomic dynamics on the sensitivity of Plasmodium falciparum isolates to piperaquine and other antimalarial drugs.
    Wakoli DM; Ondigo BN; Ochora DO; Amwoma JG; Okore W; Mwakio EW; Chemwor G; Juma J; Okoth R; Okudo C; Yeda R; Opot BH; Cheruiyot AC; Juma D; Roth A; Ogutu BR; Boudreaux D; Andagalu B; Akala HM
    BMC Med; 2022 Nov; 20(1):448. PubMed ID: 36397090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of novel
    Ajibaye O; Olukosi YA; Oriero EC; Oboh MA; Iwalokun B; Nwankwo IC; Nnam CF; Adaramoye OV; Chukwemeka S; Okanazu J; Gabriel E; Balogun EO; Amambua-Ngwa A
    Front Cell Infect Microbiol; 2024; 14():1366563. PubMed ID: 38716192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.